Double cord blood transplantation in patients with high-risk haematological diseases

被引：0
|
作者：
Ruggeri, A. [1 ]
de latour, R. Peffault [1 ]
Rocha, V. [1 ]
Madureira, A. [1 ]
Carmagnat, M. [1 ]
Larghero, J. [1 ]
Robin, M. [1 ]
Arrais, C. [1 ]
Rea, D. [1 ]
Teisserenc, H. [1 ]
Traineau, R. [1 ]
Ribaud, P. [1 ]
Ferry, C. [1 ]
Devergie, A. [1 ]
Rabian, C. [1 ]
Gluckman, E. [1 ]
Toubert, A. [1 ]
Socie, G. [1 ]
机构：
[1] Hop St Louis, Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S146 / S147
页数：2
相关论文
共 50 条
  • [21] Reduced-intensity unrelated cord-blood transplantation (RIUCBT) for patients with high-risk myeloid malignancies
    Yuji, K
    Miyakoshi, S
    Takagi, S
    Kato, D
    Miura, Y
    Narimatsu, H
    Kusumi, E
    Kishi, Y
    Matsumura, T
    Kobayashi, K
    Hamaki, T
    Uchida, N
    Kami, M
    Masuoka, K
    Murashige, N
    Wake, A
    Ueyama, J
    Yoneyama, A
    Matsuzaki, M
    Morinaga, S
    Muto, Y
    Takaue, Y
    Taniguchi, S
    BLOOD, 2005, 106 (11) : 810A - 810A
  • [22] Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation
    Iori, AP
    Cerretti, R
    De Felice, L
    Screnci, M
    Mengarelli, A
    Romano, A
    Caniglia, M
    Cerilli, L
    Gentile, G
    Moleti, ML
    Giona, F
    Agostini, F
    Pasqua, I
    Perrone, MP
    Pinto, MR
    Grapulin, L
    Testi, AM
    Martino, P
    De Rossi, G
    Mandelli, F
    Arcese, W
    BONE MARROW TRANSPLANTATION, 2004, 33 (11) : 1097 - 1105
  • [23] Successful Cord Blood Transplantation in a Werner Syndrome Patient with High-risk Myelodysplastic Syndrome
    Hayashi, Kiyohito
    Tasaka, Taizo
    Kondo, Toshinori
    Ishikawa, Yuichi
    Goto, Makoto
    Matsuhashi, Yoshiko
    Sadahira, Yoshito
    Sugihara, Takashi
    Wada, Hideho
    INTERNAL MEDICINE, 2019, 58 (01) : 109 - 113
  • [24] I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases
    H Yamamoto
    N Uchida
    N Matsuno
    A Kon
    A Nishida
    H Ota
    T Ikebe
    N Nakano
    K Ishiwata
    H Araoka
    S Takagi
    M Tsuji
    Y Asano-Mori
    G Yamamoto
    K Izutsu
    K Masuoka
    A Wake
    A Yoneyama
    S Makino
    S Taniguchi
    Bone Marrow Transplantation, 2015, 50 : 607 - 609
  • [25] I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases
    Yamamoto, H.
    Uchida, N.
    Matsuno, N.
    Kon, A.
    Nishida, A.
    Ota, H.
    Ikebe, T.
    Nakano, N.
    Ishiwata, K.
    Araoka, H.
    Takagi, S.
    Tsuji, M.
    Asano-Mori, Y.
    Yamamoto, G.
    Izutsu, K.
    Masuoka, K.
    Wake, A.
    Yoneyama, A.
    Makino, S.
    Taniguchi, S.
    BONE MARROW TRANSPLANTATION, 2015, 50 (04) : 607 - 609
  • [26] RENAL TRANSPLANTATION IN HIGH-RISK PATIENTS
    SIMMONS, RL
    KJELLSTRAND, CM
    BUSELMEIER, TJ
    NAJARIAN, JS
    ARCHIVES OF SURGERY, 1971, 103 (02) : 290 - +
  • [27] Renal transplantation in high-risk patients
    Weimert, Nicole A.
    Alloway, Rita R.
    DRUGS, 2007, 67 (11) : 1603 - 1627
  • [28] Renal Transplantation in High-Risk Patients
    Nicole A. Weimert
    Rita R. Alloway
    Drugs, 2007, 67 : 1603 - 1627
  • [29] HIGH-RISK LEUKEMIA PATIENTS BENEFIT FROM UMBILICAL CORD BLOOD TRANSPLANT
    不详
    STEM CELLS TRANSLATIONAL MEDICINE, 2016, 5 (10) : XII - XIII
  • [30] Reduced-intensity unrelated cord blood transplantation (RICBT) in adult patients with high-risk hematological malignancies.
    Morii, T
    Amano, I
    Tanaka, H
    Takahashi, T
    Kimura, H
    BLOOD, 2005, 106 (11) : 444B - 445B
12345